Skip to main content

Bancel Stephane's Form 4 filing

Moderna, Inc. (MRNA) · filed Mar 3, 2023

Accession no.
0001127602-23-008679
Filed
Mar 3, 2023
Trade date
Mar 1-2, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 10 non-derivative transactions and 2 derivative transactions. Open-market sales total $10.9M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Bancel StephaneCIK 0001443340Director, Officer (Chief Executive Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 1, 2023Common StockMOption exerciseAcquired+40,000$0.99+$39,6005,451,946Direct
Mar 1, 2023Common StockSSaleDisposed−11,319$134.34F4−$1,520,594.465,440,627Direct
Mar 1, 2023Common StockSSaleDisposed−21,938$135.26F5−$2,967,333.885,418,689Direct
Mar 1, 2023Common StockSSaleDisposed−5,593$136.17F6−$761,598.815,413,096Direct
Mar 1, 2023Common StockSSaleDisposed−1,150$137.03F7−$157,584.55,411,946Direct
Mar 2, 2023Common StockMOption exerciseAcquired+40,000$0.99+$39,6005,451,946Direct
Mar 2, 2023Common StockSSaleDisposed−8,700$136.44F8−$1,187,0285,443,246Direct
Mar 2, 2023Common StockSSaleDisposed−17,541$137.42F9−$2,410,484.225,425,705Direct
Mar 2, 2023Common StockSSaleDisposed−13,659$138.27F10−$1,888,629.935,412,046Direct
Mar 2, 2023Common StockSSaleDisposed−100$139.03−$13,9035,411,946Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 1, 2023Common StockMOption exerciseDisposed−40,000$0.00$01,347,155Direct
Mar 2, 2023Common StockMOption exerciseDisposed−40,000$0.00$01,307,155Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F4

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $133.79 to $134.79. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F5

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $134.80 to $135.79. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F6

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $135.81 to $136.80. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F7

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $136.82 to $137.58. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F8

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $135.88 to $136.88. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F9

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $136.89 to $137.89. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F10

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $137.90 to $138.90. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)